These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 25310132)
1. The AIDS response catalysing economic and social transformation: the importance of local pharmaceutical production. Sidibé M Antivir Ther; 2014; 19 Suppl 3():3-4. PubMed ID: 25310132 [No Abstract] [Full Text] [Related]
2. Production of antiretroviral drugs in middle- and low-income countries. Pinheiro Edos S; Brüning K; Macedo MF; Siani AC Antivir Ther; 2014; 19 Suppl 3():49-55. PubMed ID: 25310755 [TBL] [Abstract][Full Text] [Related]
3. The discovery and development of antiretroviral agents. Lange JM; Ananworanich J Antivir Ther; 2014; 19 Suppl 3():5-14. PubMed ID: 25310317 [TBL] [Abstract][Full Text] [Related]
4. TRIPS post-2005 and access to new antiretroviral treatments in southern countries: issues and challenges. Orsi F; D'Almeida C; Hasenclever L; Camara M; Tigre P; Coriat B AIDS; 2007 Oct; 21(15):1997-2003. PubMed ID: 17885289 [No Abstract] [Full Text] [Related]
5. Production of low cost AIDS drugs to continue in Brazil. Reprod Health Matters; 2001 Nov; 9(18):178. PubMed ID: 11803899 [No Abstract] [Full Text] [Related]
6. Active pharmaceutical ingredients for antiretroviral treatment in low- and middle-income countries: a survey. Fortunak JM; de Souza RO; Kulkarni AA; King CL; Ellison T; Miranda LS Antivir Ther; 2014; 19 Suppl 3(0 3):15-29. PubMed ID: 25310430 [TBL] [Abstract][Full Text] [Related]
7. Intellectual property rights, market competition and access to affordable antiretrovirals. Pascual F Antivir Ther; 2014; 19 Suppl 3():57-67. PubMed ID: 25309984 [TBL] [Abstract][Full Text] [Related]
8. Low-cost generic drugs under the President's Emergency Plan for AIDS Relief drove down treatment cost; more are needed. Venkatesh KK; Mayer KH; Carpenter CC Health Aff (Millwood); 2012 Jul; 31(7):1429-38. PubMed ID: 22778332 [TBL] [Abstract][Full Text] [Related]
9. Hope for South Africa--at last. Lancet; 2003 Aug; 362(9383):501. PubMed ID: 12932376 [No Abstract] [Full Text] [Related]
10. Working together to provide generics for health. Beck EJ; Reiss P Antivir Ther; 2014; 19 Suppl 3():1. PubMed ID: 25310234 [No Abstract] [Full Text] [Related]
11. Dispatches from the front line. Nature; 2002 Aug; 418(6897):465. PubMed ID: 12152038 [No Abstract] [Full Text] [Related]
12. World Trade Organization still threatens supply of affordable AIDS drugs. Hagmann M Bull World Health Organ; 2002; 80(9):762-3. PubMed ID: 12378300 [No Abstract] [Full Text] [Related]
13. HIV/AIDS: Latin America & Caribbean. Brazil: ten years after. Cohen J Science; 2006 Jul; 313(5786):484-7. PubMed ID: 16873654 [No Abstract] [Full Text] [Related]
14. Trans-Pacific trade pact triggers fears over drug prices. McCall C Lancet; 2015 Jun; 385(9986):2450-1. PubMed ID: 26122057 [No Abstract] [Full Text] [Related]
15. Indian company seeks US approval for generic AIDS drugs. Nature; 2004 Aug; 430(7001):716. PubMed ID: 15306779 [No Abstract] [Full Text] [Related]
16. Access to HIV drugs: are we changing the two world paradigm? Lazzarini Z Conn J Int Law; 2002; 17(2):281-96. PubMed ID: 12688297 [No Abstract] [Full Text] [Related]
17. Do patents prevent access to drugs for HIV in developing countries? Selgelid MJ; Schuklenk U JAMA; 2002 Feb; 287(7):842-3. PubMed ID: 11851570 [No Abstract] [Full Text] [Related]
18. Do patents prevent access to drugs for HIV in developing countries? Goemaere E; Kaninda AV; Ciaffi L; Mulemba M; t Hoen E; Pécoul B JAMA; 2002 Feb; 287(7):841-2; author reply 842-3. PubMed ID: 11851569 [No Abstract] [Full Text] [Related]
19. Canada's plan to sell generic drugs to developing countries is threatened. Spurgeon D BMJ; 2004 Mar; 328(7442):728. PubMed ID: 15044278 [No Abstract] [Full Text] [Related]
20. Affordable drug access for developing countries. Highleyman L BETA; 2001; 14(2):12-25. PubMed ID: 11785481 [No Abstract] [Full Text] [Related] [Next] [New Search]